Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gougerot-Sjogren-like syndrome under PD-1 inhibitor treatment.

× No keyword cloud information.

9 in total

1. Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.

Authors: Ariadna Ortiz Brugués; Vincent Sibaud; Beatrice Herbault-Barrés; Sarah Betrian; Iphigenie Korakis; Caroline De Bataille; Carlos Gomez-Roca; Joel Epstein; Emmanuelle Vigarios
Journal: Oncologist Date: 2019-11-06

2. Diagnostic Dilemma of Paraneoplastic Rheumatic Disorders: Case Series and Narrative Review.

Authors: Youngmin Cho; Erik W Anderson; Sara J Guevara; Santiago J Miyara; Naomi Maria; Christine N Metz; Stefanos Zafeiropoulos; Dimitrios Giannis; Jifeng Wang; Oluseyi Abidoye; James M Mumford; Judith Aronsohn; Ernesto Molmenti; Huma Sohail
Journal: Cureus Date: 2021-11-29

Review 3. Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature.

Authors: Devis Benfaremo; Lucia Manfredi; Michele Maria Luchetti; Armando Gabrielli
Journal: Curr Drug Saf Date: 2018

4. Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.

Authors: Marie Kostine; Marie-Elise Truchetet; Thierry Schaeverbeke
Journal: Rheumatology (Oxford) Date: 2019-12-01 Impact factor: 7.580

5. Management of rheumatic complications of immune checkpoint inhibitor therapy - an oncological perspective.

Authors: Neil M Steven; Benjamin A Fisher
Journal: Rheumatology (Oxford) Date: 2019-12-01 Impact factor: 7.580

6. Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.

Authors: Noha Abdel-Wahab; Maria E Suarez-Almazor
Journal: Rheumatology (Oxford) Date: 2019-12-01 Impact factor: 7.580

7. Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer.

Authors: Tetsuo Higashi; Hideaki Miyamoto; Ryoji Yoshida; Yoki Furuta; Katsuya Nagaoka; Hideaki Naoe; Hisaki Naito; Hideki Nakayama; Motohiko Tanaka
Journal: Intern Med Date: 2020-06-23 Impact factor: 1.271

Review 8. Oral Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors: Salivary Gland Dysfunction and Mucosal Diseases.

Authors: Yoshiaki Yura; Masakazu Hamada
Journal: Cancers (Basel) Date: 2022-02-04 Impact factor: 6.639

Review 9. Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer.

Authors: Lin Zhou; Xin Wei
Journal: Front Immunol Date: 2021-08-24 Impact factor: 7.561

9 in total